微信直播

YK Chao, SYK Law 和谭黎杰:两岸三地食管癌治疗差异

Published at: 2015年第1卷第S1期

郑燕 , 黎少灵
关键词:

编者按:第24届亚洲胸心外科协会(ASCVTS)暨第4届亚洲单孔胸腔镜论坛(ASPVS)于2016年4月6-10日在台北国际会议中心举行。正式大会在4月4月8日开幕,前两天会议分别为海峡两岸交流会和AATS Postgraduate course。

 

秉承着快乐学术、促进交流的会议报道宗旨,AME出版社以展台为线下基地,在会议期间展开了一场“East meets West, junior meets senior”的对话运动,即由国内优秀中青年医师组成的AME特邀记者团与国际学科意见领袖(Key opinion leader)就相关热点话题进行访谈对话。

AME特邀记者、来自河南省肿瘤医院的郑燕医师和中山大学肿瘤医院的杨弘医师对话长庚纪念医院的赵盈凯(Yin-Kai Chao)教授、香港大学的Simon Law教授、上海中山医院的谭黎杰教授,大家就两岸三地食管癌的综合治疗进行探讨。其中,香港和台湾都是遵循NCCN指南进行术前放化疗,而中国内陆很多时候都是直接行手术治疗。新辅助放化疗的依据来自CROSS研究,但CROSS研究和法国的9901研究对术前放化疗的结果是存在矛盾的。同时CROSS研究的根治切除率过低,新辅助放化疗还有很多值得探索。日本目前的标准综合治疗方案是术前化疗,其1109研究将会对比术前化疗与术前放化疗的区别,结果会提示哪种综合治疗方案更好,我们是否能弃用术前放疗。


图1. 4月9日胸外科专场讲者合影(左-右):长庚纪念医院的赵盈凯(Yin-Kai Chao)教授,台大医院李章铭教授,上海中山医院的谭黎杰教授,日本Tokai University School of Medicine的Soji Ozawa教授,韩国Yonsei University College of Medicine的Dae Joon Kim教授,香港大学的Simon YK Law教授。

郑燕医师、杨弘医师对话Yin-Kai Chao教授、Simon Law 教授和谭黎杰

图2. 大家在采访之后自由讨论

 

受访专家

Yin-Kai Chao, M.D., Ph.D 

  • Dr. Chao acquired his MD degree from Chang Gung university in 2001 and completed specialist training as thoracic surgeon in Chang Gung Memorial Hospital in 2006. In 2010, he received PhD degree in Medical sciences at the Chang Gung University. He is now the full time attending staff in the Department of Thoracic and Cardiovasvular Surgery in Chang Gung memorial hospital Linkou and an associate professor at Chang Gung University.

  • Dr. Chao is a board certified surgeon pioneering in minimal invasive esophagectomy. He accounts for more than 60% of the esophageal cancer operations performed annually at Chang Gung Memorial Hospital, Linkou,Taiwan. Dr. Chao is a very strong patient advocate and very dedicated to our specialty, his talent in minimal invasive surgery is outstanding and exemplary and of the highest quality.

  • In addition to his work, Dr Chao is also a well-known researcher . His areas of scientific investigation include the esophageal cancer research and development of biodegradable medical device. Being a recipient of numerous research awards since 2006, he has authored over 50 publications.

  • Dr. Yin-Kai Chao is a very well-known doctor in the esophageal cancer field. His innovative surgical methods as well as his experienced techniques have gained him recognition and praise in Taiwan.

Simon YK Law, MBBChir (Cantab), MS (HK), MA, FRCSEd, FCSHK, FHKAM, FACS

  • Prof. Law graduated from the University of Cambridge in England in 1987 with First Class Honors and completed his clinical curriculum at the same university. He received his post-graduate training at The University of Hong Kong. He became Clinical Professor in Surgery in 2005. He is currently Cheung Kung-Hai Professor in Gastrointestinal Surgery, and Chief of the Division of Esophageal and Upper Gastrointestinal Surgery at The University of Hong Kong.

  • Prof. Law has concentrated his experience and research in upper gastrointestinal tract disorders, with emphasis on esophageal and gastric cancers, motility disorders and gastro-esophageal reflux disease. He has focused on endoscopic diagnostic and treatment techniques on foregut diseases, surgical methods including minimally invasive and robot-assisted surgery, and multimodality treatments of esophageal and gastric cancers.

  • He is a council member of the College of Surgeons of Hong Kong. He plays an active role in many international societies, holding positions such as Executive Council Member of the International Society of Digestive Surgery (ISDS), Asia Representative of the Member Services Committee of the Society for Surgeons of the Alimentary Tract (SSAT). He is the current Secretary of the Hong Kong China Chapter of the American College of Surgeons.

  • Prof. Law has published over 400 articles and abstracts, and 30 book chapters, including those in Mastery of Surgery, Maingot’s Abdominal Operations, Pearson’s Thoracic and Esophageal Surgery and Shackelford’s Surgery of the Alimentary Tract. He is associate editor of the Diseases of the Esophagus, and editor to other leading surgical publications such as Annals of Surgery, Surgery, JAMA Surgery, and World Journal of Surgery. Professor Law is also the Editorial Board Member of the journal Translational Gastrointestinal Cancer (TGC)

谭黎杰

  • 主任医师,外科学博士,博士生导师,复旦大学附属中山医院胸外科副主任,食管外科主任,上海市呼吸病研究所细胞与分子生物学研究室副主任。中国抗癌协会食管癌专业委员会委员、中国医师协会胸外科分会食管外科专家委员会委员、中国医师协会内镜医师分会理事、中国食管疾病学会常委(Chinese Society of Disease of the Esophagus, CSDE)、中国医疗促进会胸外科分会委员,上海市抗癌协会胸部肿瘤分会微创学组组长、上海市肿瘤学会胸部肿瘤学组委员、上海市中西医结合学会胸外科分会常委。是ISDE、ITMIG等多个国际研究性组织成员。担任“Journal of Thoracic Disease”、”中华胸外科杂志”、“中国微创外科杂志”、“食管外科”等杂志编委及ATS, EJCTS/ITCVS, ASO, CMJ 等多本杂志审稿人。以第一或通讯作者发表论文60余篇,其中SCI收入20余篇。主编“Uniportal Video-Assisted Thoracic Surgery”(中英文版)、“Uniportal Thoracoscopic Surgery” (中英语版)、副主译“Atlas of Minimally Invasive Esophagectomy”。主持完成科研项目“胸腹腔镜食管癌根治术的技术优化和推广”获上海市医学科技奖。

AME特邀记者|郑燕,河南省肿瘤医院胸外科;杨弘,中山大学肿瘤医院胸外科。

编辑|黎少灵,AME出版社。

相关阅读:

doi:10.3978/kysj.2014.1.1818

comments powered by Disqus

附件